Correction to: N6‑methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer
| Published in: | Cancer Cell International |
|---|---|
| Main Authors: | Chunying Zhang, Jiadi Chen, Jingyi Ren, Xiaoyu Li, Yaqin Zhang, Bihan Huang, Yihan Xu, Luyan Dong, Yingping Cao |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-04-01
|
| Online Access: | https://doi.org/10.1186/s12935-024-03303-7 |
Similar Items
N6-methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer
by: Chunying Zhang, et al.
Published: (2024-03-01)
by: Chunying Zhang, et al.
Published: (2024-03-01)
Downregulating LKB1 in bone marrow mesenchymal stem cells could inhibit CD4+ T cell proliferation via the PD-1/PD-L1 signaling pathway
by: Yaqin Zhang, et al.
Published: (2024-11-01)
by: Yaqin Zhang, et al.
Published: (2024-11-01)
Peripheral Blood Non-Coding RNA as Biomarker for Schizophrenia: A Review
by: Mengtong Xie, et al.
Published: (2024-02-01)
by: Mengtong Xie, et al.
Published: (2024-02-01)
Methyltransferase-like 3-mediated RNA N6-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target
by: Deshuang Zhang, et al.
Published: (2025-03-01)
by: Deshuang Zhang, et al.
Published: (2025-03-01)
RNA N6-methyladenosine methylation and skin diseases
by: Yaqin Yu, et al.
Published: (2023-12-01)
by: Yaqin Yu, et al.
Published: (2023-12-01)
Peripheral blood microbiome signature and Mycobacterium tuberculosis-derived rsRNA as diagnostic biomarkers for tuberculosis in human
by: Wei Gu, et al.
Published: (2025-02-01)
by: Wei Gu, et al.
Published: (2025-02-01)
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
by: Fei Ye, et al.
Published: (2021-07-01)
by: Fei Ye, et al.
Published: (2021-07-01)
Comprehensive Analysis of Differentially Expressed Profiles of mRNA N6-Methyladenosine in Colorectal Cancer
by: Na Li, et al.
Published: (2022-01-01)
by: Na Li, et al.
Published: (2022-01-01)
Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease
by: Yuan Hui, et al.
Published: (2023-09-01)
by: Yuan Hui, et al.
Published: (2023-09-01)
Multicenter Validation of lncRNA and Target mRNA Diagnostic and Prognostic Biomarkers of Acute Ischemic Stroke From Peripheral Blood Leukocytes
by: Jialing Mu, et al.
Published: (2024-07-01)
by: Jialing Mu, et al.
Published: (2024-07-01)
RNA N6-methyladenosine modification-based biomarkers for absorbed ionizing radiation dose estimation
by: Hongxia Chen, et al.
Published: (2023-10-01)
by: Hongxia Chen, et al.
Published: (2023-10-01)
The distribution and significance of RNA N6-methyladenosine regulators in osteoarthritis for diagnostic and subtype identification
by: Yulong Hou, et al.
Published: (2025-10-01)
by: Yulong Hou, et al.
Published: (2025-10-01)
N6-methyladenosine modification of B7-H3 mRNA promotes the development and progression of colorectal cancer
by: Rui Chen, et al.
Published: (2024-02-01)
by: Rui Chen, et al.
Published: (2024-02-01)
Role of N6‐methyladenosine RNA modification in cancer
by: Yi Qu, et al.
Published: (2024-09-01)
by: Yi Qu, et al.
Published: (2024-09-01)
TUSC3 methylation in peripheral blood cells as a biomarker for diagnosis of colorectal cancer
by: Goli Siri, et al.
Published: (2023-01-01)
by: Goli Siri, et al.
Published: (2023-01-01)
LncRNA of peripheral blood mononuclear cells: HYMAI acts as a potential diagnostic and therapeutic biomarker for female major depressive disorder
by: Tianyi Bu, et al.
Published: (2025-02-01)
by: Tianyi Bu, et al.
Published: (2025-02-01)
N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA
by: Zhongyuan Zhang, et al.
Published: (2021-10-01)
by: Zhongyuan Zhang, et al.
Published: (2021-10-01)
Role of N6-methyladenosine RNA modification in gastric cancer
by: Si-Qi Ding, et al.
Published: (2023-07-01)
by: Si-Qi Ding, et al.
Published: (2023-07-01)
Peripheral blood biomarkers as differential diagnostic markers of disease severity in neonates with hyperbilirubinemia
by: Dereje Mengesha Berta, et al.
Published: (2025-01-01)
by: Dereje Mengesha Berta, et al.
Published: (2025-01-01)
Research progress of N1-methyladenosine RNA modification in cancer
by: Yafeng Liu, et al.
Published: (2024-01-01)
by: Yafeng Liu, et al.
Published: (2024-01-01)
Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
by: Qianru Zhu, et al.
Published: (2022-10-01)
by: Qianru Zhu, et al.
Published: (2022-10-01)
Histone crotonylation of peripheral blood mononuclear cells is a potential biomarker for diagnosis of colorectal cancer
by: Jia-Yi Hou, et al.
Published: (2023-09-01)
by: Jia-Yi Hou, et al.
Published: (2023-09-01)
Reversible RNA Modification N1-methyladenosine (m1A) in mRNA and tRNA
by: Chi Zhang, et al.
Published: (2018-06-01)
by: Chi Zhang, et al.
Published: (2018-06-01)
RNA N6-Methyladenosine Modifications and the Immune Response
by: Ya-Nan Wang, et al.
Published: (2020-01-01)
by: Ya-Nan Wang, et al.
Published: (2020-01-01)
The roles of RNA N6-methyladenosine in esophageal cancer
by: Chuan Teng, et al.
Published: (2022-11-01)
by: Chuan Teng, et al.
Published: (2022-11-01)
N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
by: Chi Liu, et al.
Published: (2022-04-01)
by: Chi Liu, et al.
Published: (2022-04-01)
Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer
by: Xingyu Zhong, et al.
Published: (2025-04-01)
by: Xingyu Zhong, et al.
Published: (2025-04-01)
N7-methyladenosine-induced SLC7A7 serves as a prognostic biomarker in pan-cancer and promotes CRC progression in colorectal cancer
by: Fuqi Wang, et al.
Published: (2024-12-01)
by: Fuqi Wang, et al.
Published: (2024-12-01)
Identification of microRNA Signatures in Peripheral Blood of Young Women as Potential Biomarkers for Metal Allergy
by: Yuehui Zhang, et al.
Published: (2023-01-01)
by: Yuehui Zhang, et al.
Published: (2023-01-01)
Landscape of N1‐methyladenosin (m1A) modification pattern in colorectal cancer
by: Chunhui Jiang, et al.
Published: (2024-02-01)
by: Chunhui Jiang, et al.
Published: (2024-02-01)
Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network
by: Yajing Zhao, et al.
Published: (2022-09-01)
by: Yajing Zhao, et al.
Published: (2022-09-01)
The potential role of RNA N6-methyladenosine in primary Sjögren’s syndrome
by: Qiufeng Xiao, et al.
Published: (2022-11-01)
by: Qiufeng Xiao, et al.
Published: (2022-11-01)
N6-methyladenosine RNA modification regulates photosynthesis during photodamage in plants
by: Man Zhang, et al.
Published: (2022-12-01)
by: Man Zhang, et al.
Published: (2022-12-01)
Peripheral blood RNA biomarkers can predict lesion severity in degenerative cervical myelopathy
by: Zhenzhong Zheng, et al.
by: Zhenzhong Zheng, et al.
Downregulation of microRNA‐6125 promotes colorectal cancer growth through YTHDF2‐dependent recognition of N6‐methyladenosine‐modified GSK3β
by: Hongyan Li, et al.
Published: (2021-10-01)
by: Hongyan Li, et al.
Published: (2021-10-01)
AMeta-analysis of blood miRNA as a diagnostic biomarker for endometriosis
by: Liu Chang, et al.
Published: (2022-12-01)
by: Liu Chang, et al.
Published: (2022-12-01)
N6-methyladenosine mRNA methylation is important for the light response in soybean
by: Liya Zhang, et al.
Published: (2023-04-01)
by: Liya Zhang, et al.
Published: (2023-04-01)
N 6-methyladenosine regulates RNA abundance of SARS-CoV-2
by: Ting Zhang, et al.
Published: (2021-01-01)
by: Ting Zhang, et al.
Published: (2021-01-01)
β-Cyclodextrin-Modified Laser-Induced Graphene Electrode for Detection of <i>N</i>6-Methyladenosine in RNA
by: Jingyi Guo, et al.
Published: (2024-10-01)
by: Jingyi Guo, et al.
Published: (2024-10-01)
Regulation of viral hepatitis by N6-methyladenosine RNA methylation
by: Jae-Su Moon, et al.
Published: (2025-12-01)
by: Jae-Su Moon, et al.
Published: (2025-12-01)
Similar Items
-
N6-methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer
by: Chunying Zhang, et al.
Published: (2024-03-01) -
Downregulating LKB1 in bone marrow mesenchymal stem cells could inhibit CD4+ T cell proliferation via the PD-1/PD-L1 signaling pathway
by: Yaqin Zhang, et al.
Published: (2024-11-01) -
Peripheral Blood Non-Coding RNA as Biomarker for Schizophrenia: A Review
by: Mengtong Xie, et al.
Published: (2024-02-01) -
Methyltransferase-like 3-mediated RNA N6-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target
by: Deshuang Zhang, et al.
Published: (2025-03-01) -
RNA N6-methyladenosine methylation and skin diseases
by: Yaqin Yu, et al.
Published: (2023-12-01)
